EMA Addresses Calls To Publish COVID-19 Clinical Data

The European Medicines Agency’s clinical data publication policy is on hold, but calls are growing for the regulator to start publishing trial data for COVID-19 treatments and vaccines as soon as they are authorized in the EU.

PS2004_Clinical Trials_1095927122_1200.jpg — Rapid access to clinical data on approved COVID-19 medicines could help other researchers • Source: Shutterstock

The European Medicines Agency is looking at its temporarily stalled clinical data publication policy and exploring how it might for now make public the trial data supporting any COVID-19 vaccines or treatments that are authorized in the EU.

“We are currently discussing how to enhance the level of transparency for COVID-19 procedures, including the possibility of rapidly publishing...